New strategic agreements with the medicines industry – PBS website updates

1 July 2022 - Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 give effect to ...

Read more →

MAP offers new online pathway for accessing cancer treatments

25 February 2022 - Medicines Australia and Rare Cancers Australia yesterday provided pharmaceutical industry stakeholders a preview of a new ...

Read more →

Does the DoH favour some pharmaceutical companies over others?

23 February 2022 - Some interesting insights from version 1 of the agenda for the May 2022 PBAC (intracycle) meeting. ...

Read more →

COVID-19 pandemic sends clear message that Australia must value the long-term health of all Australians

21 February 2022 - Medicines Australia is warning that Australia must act now to ensure that our health system is ...

Read more →

Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

Additional insights from the agenda for the March 2022 PBAC meeting

26 November 2021 - More insights from the MAESTrO Team. ...

Read more →

MSD Australia endorses new medicines strategic agreement

8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...

Read more →

Landmark new medicines agreements to bring significant benefits for Australian patients

7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...

Read more →

New strategic agreements with the medicines industry

7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...

Read more →

The Government and Medicines Australia jointly agree to finalise patient centric strategic agreement after the Budget

8 May 2021 - Medicines Australia has been working closely with the Minister and his Department since last year to ...

Read more →

Investment in innovative medicines needed to safeguard Australia’s long-term prosperity

17 March 2021 - Medicines Australia has lodged its 2021-22 Pre-Budget Submission with The Treasury which outlines several recommendations to ...

Read more →

Medicines Australia joins forces with 15 health care organisations to highlight continuity of care

6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...

Read more →

Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies

26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...

Read more →

Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC

3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...

Read more →

'Cannot be trusted ... causing harm': top medical journal takes on big pharma

4 December 2019 - A leading medical journal is launching a global campaign to separate medicine from big pharma, linking ...

Read more →